Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey

Drug overdoses surged during the COVID-19 pandemic, underscoring the need for expanded and accessible substance use disorder (SUD) treatment.

Original research | 2022
About PWUD, Substitution/OAT, Digital health, Carries/take-home doses

Funding and management of naloxone programs in Canada

This Environmental Scan provides an overview of how naloxone is made available in Canadian jurisdictions, with a focus on take-home naloxone programs.
Report | 2018
Overdose, Harm reduction, Policy/Regulatory, Wrap-around services, About pharmacists

Guide for Injecting Tablet Medication

A resource for anyone who is injecting tablet medications (pills) and would like to do so more safely.

Video | 2020
Harm reduction, About PWUD, Injecting drugs

Homelessness and publicly funded substance use disorder treatment in California, 2016–2019: Analysis of treatment needs, level of care placement, and outcomes

The objective of this paper is to develop a better understanding of the SUD services that PEH receive in publicly funded treatment programs by (1) describing the characteristics and needs of the PEH p
Original research | 2021
Wrap-around services, About PWUD, Outcomes, Poverty, Housing, Legal system/law enforcement, Illegal drugs, Mental health

Impact of participation in a peer-led overdose program for people who use drugs

This study explores the personal impact, including benefits and apprehensions, for PWUD who participated in a peer-led overdose prevention program and did not intervene post-training.
Original research | 2022
Overdose, Harm reduction, About PWUD, Outcomes, Illegal drugs, Peer/PWLLE program involvement, Social benefits

Interim opioid agonist treatment for opioid addiction: a systematic review

The study’s objective is to review the impact of interim opioid agonist treatment (OAT), a short-term approach for patients awaiting standard OAT, in terms of treatment retention, access to standard O
Lit review | 2022
Harm reduction, About PWUD, Substitution/OAT, Transitions in care/treatment

Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions

Opioid agonist therapy (OAT) has been severely disrupted by the COVID-19 pandemic.
Lit review | 2021
Harm reduction, Policy/Regulatory, Equity, About prescribers, About PWUD, Barriers and enablers

Mobile low-threshold buprenorphine integrated with infectious disease services

In 2018, the Baltimore City Health Department launched a mobile clinic called Healthcare on The Spot, which offers low-threshold buprenorphine services integrated with health care services to meet the
Original research | 2022
Harm reduction, Wrap-around services, Social services, Outcomes, Substitution/OAT

Overdose deaths and the COVID-19 pandemic in British Columbia, Canada

This analysis reports on changes in the profile of people who have died of overdose since BC's declaration of COVID-19 as a public health emergency on 17 March 2020.
Original research | 2021
Overdose, Mortality, About PWUD, Outcomes, Illegal drugs, Sex/Gender

Relationship Between Social Determinants and Opioid Use Disorder Treatment Outcomes by Gender

This study aims to identify social correlates of OUD treatment outcomes from five key areas of social determinants separately for men and women receiving buprenorphine for OUD.
Original research | 2022
About PWUD, Illegal drugs, Substitution/OAT, Sex/Gender

Smart Syringe Vending Machines: Research Capabilities and Implications for Research Data Collection

Syringe vending machines (SVMs) are intended to supplement the standard syringe exchange programs to access hard-to-reach groups and to cover unserved geographical areas.
Original research | 2021
About PWUD, Social services, Digital health

Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial

Heroin-assisted treatment is eff ective for methadone treatment-refractory heroin-dependent patients, but continued comorbid cocaine dependence remains problematic.
Original research | 2016
Safer supply, About PWUD, Outcomes, Illegal drugs, Stimulants

The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction

During the pandemic, addiction support became more challenging, as existing health care models had changed or been completely abolished.
Original research | 2022
Overdose, Mortality, Policy/Regulatory, About prescribers, Social services, Workplace, Mental health

Toward a positive psychology of psychoactive drug use

This article advances the proposition that contemporary perspectives on psychoactive drug use are epistemologically limited and that a broadened conceptualization of substance use would aid the develo
Original research | 2021
Policy/Regulatory, Advocacy, About PWUD, Illegal drugs

Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl, and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018–December 2019

This study aimed to determine whether integrating death certificate data with medical examiner/coroner reports, including postmortem toxicology and death investigation findings, would enhance identifi
Original research | 2021
Overdose, Mortality, Evidence base, Illegal drugs

Wound Bed Preparation 2021

To present the 2021 update of the Wound Bed Preparation paradigm
Guidelines | 2021
Clinical guidance, Wrap-around services, About prescribers, Chronic pain, Injecting drugs

Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey

Patient-centeredness is a cornerstone of substance use disorder (SUD) treatment.
Original research | 2022
About prescribers, Barriers and enablers, Substitution/OAT, Transitions in care/treatment

Boîte à outils pour la mise en place d’un site répondant à un besoin urgent en matière de santé publique (SBUSP)

Guide or handbook | 2021
Overdose, Clinical guidance, Harm reduction, About prescribers, Social services, Illegal drugs, SCS/OPS

Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People

The objective of this study was to identify variables associated with buprenorphine/naloxone retention among Alaska Native and American Indian people with opioid use disorder
Original research | 2021
Equity, About PWUD, Outcomes, Illegal drugs, Indigenous, Substitution/OAT

Causes of death among people who used illicit opioids in England, 2001–18: a matched cohort study

In many countries, the average age of people who use illicit opioids, such as heroin, is increasing.
Original research | 2021
Mortality, About PWUD, Outcomes, Illegal drugs

Affiner votre recherche

Mots clés
Format
Région